A Promising Path Forward in Obesity Pharmacotherapy: Ecnoglutide and the Evolution of GLP-1R Agonist Design
1Stem Cells and Tissue Engineering Manufacture Center, School of Life Science, National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei University , Wuhan 430062, China
2 Department of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong , Hong Kong, SAR, China
3 Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China , Chengdu, China
4 Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, College of Basic Medicine, Hubei University of Medicine , Shiyan 442000, China
Liangbin Zhou, Stem Cells and Tissue Engineering Manufacture Center, School of Life Science, National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei University, Wuhan 430062, China and Department of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong, Hong Kong SAR, China, E-mail:
jacobchou@link.cuhk.edu.hk;
Dongze Wu, Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China, E-mail:
dongze_wu@163.com;
Xiangdong Ye, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, College of Basic Medicine, Hubei University of Medicine, Shiyan 442000, China, E-mail:
yexiangdong@hbmu.edu.cn
Show less
PDF
(1533KB)
